The latest price target for Aspen Aerogels (NYSE:ASPN) was reported by Barclays on May 11, 2026. The analyst firm set a price target for $4.00 expecting ASPN to fall to within 12 months (a possible -33.77% downside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Aspen Aerogels (NYSE:ASPN) was provided by Barclays, and Aspen Aerogels maintained their underweight rating.

There is no last upgrade for Aspen Aerogels

The last downgrade for Aspen Aerogels Inc happened on August 11, 2025 when Barclays changed their price target from $7 to $6 for Aspen Aerogels Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspen Aerogels, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspen Aerogels was filed on May 11, 2026 so you should expect the next rating to be made available sometime around May 11, 2027.

While ratings are subjective and will change, the latest Aspen Aerogels (ASPN) rating was a maintained with a price target of $3.00 to $4.00. The current price Aspen Aerogels (ASPN) is trading at is $6.04, which is out of the analyst’s predicted range.